| scholarly article | Q13442814 |
| P50 | author | Adriana Albini | Q37829005 |
| Douglas M. Noonan | Q37829014 | ||
| Roberto Benelli | Q57248514 | ||
| P2093 | author name string | L Santi | |
| D Giunciuglio | |||
| S Carlone | |||
| R Adatia | |||
| P2860 | cites work | Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA | Q24646731 |
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Basement membrane complexes with biological activity | Q28285072 | ||
| Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation | Q28296150 | ||
| Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor | Q29616189 | ||
| A human beta-actin expression vector system directs high-level accumulation of antisense transcripts | Q34638492 | ||
| Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. | Q35965194 | ||
| Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation | Q36618743 | ||
| Fibroblast chemotaxis | Q39829706 | ||
| Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis | Q42476789 | ||
| Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms | Q48138909 | ||
| Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
| In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity | Q70890126 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1257-1261 | |
| P577 | publication date | 1997-12-01 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA. | |
| P478 | volume | 8 |
| Q41895425 | A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor |
| Q30321132 | Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells |
| Q24564477 | Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo |
| Q37941513 | Antithetic roles of proteoglycans in cancer. |
| Q37494563 | Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis. |
| Q89497261 | Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan |
| Q52375995 | Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion. |
| Q33944132 | Chemical Tumor Biology of Heparan Sulfate Proteoglycans |
| Q42482003 | Differential expression of perlecan receptors, α-dystroglycan and integrin β1, before and after invasion of oral squamous cell carcinoma |
| Q42482870 | Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signalling pathways for cellular growth and differentiation |
| Q28294512 | Essential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesis |
| Q39855007 | Evaluation of 5-hydroxy-2,3-diaryl (substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anti angiogenic and anticancer agents |
| Q28142123 | Fibroblast growth factor-binding protein is a novel partner for perlecan protein core |
| Q24674858 | Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells |
| Q34475894 | Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity |
| Q34328750 | Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena |
| Q79314029 | Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion |
| Q54572622 | Matrix proteins from smoke-exposed fibroblasts are pro-proliferative. |
| Q39685717 | Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. |
| Q34114308 | Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors |
| Q37094730 | Novel interactions of perlecan: unraveling perlecan's role in angiogenesis. |
| Q45001291 | Perlecan Heparan Sulfate Is Required for the Inhibition of Smooth Muscle Cell Proliferation by All-trans-Retinoic Acid |
| Q35562693 | Perlecan and tumor angiogenesis |
| Q34548326 | Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro |
| Q54069183 | Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth? |
| Q28140820 | Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan |
| Q34706643 | Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. |
| Q36787608 | Proteoglycans in cancer biology, tumour microenvironment and angiogenesis |
| Q51732657 | Proteoglycans-Biomarkers and Targets in Cancer Therapy. |
| Q92966660 | Rodent Glioma Models: Intracranial Stereotactic Allografts and Xenografts |
| Q42317502 | Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer. |
| Q28145823 | The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7 |
| Q34439560 | The sweet and sour of cancer: glycans as novel therapeutic targets |
| Q89736315 | Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function |
| Q33897782 | Tumor attenuation by combined heparan sulfate and polyamine depletion. |
Search more.